Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am J Ophthalmol. 2020 Aug 11;221:105–114. doi: 10.1016/j.ajo.2020.08.002

Table 2.

Associations of the outcome of sensitivity loss ≥ 6dB during treatment with predictor variables including locus characteristics and participant cohort, using data of loci with baseline sensitivity ≥ 6 dB (total N = 1613 such loci)

Observed No. of events/Total No. of loci (%) Bivariable model Multivariable model
Unadjusted ORs (95%CI) p-value* Adjusted ORs (95%CI) p-value*
Participant cohort .004 .033
C1 67/427 (15.69) Ref Ref
C2 28/536 (5.22) 0.27 (0.13, 0.59) 0.34 (0.14, 0.79)
C3 24/650 (3.69) 0.28 (0.09, 0.86) 0.33 (0.11, 1.02)
Locus own baseline sensitivity .019 .034
>12 dB 48/990 (4.85) Ref Ref
> 8 and ≤ 12dB 34/358 (9.50) 1.63 (1.15, 2.31) 1.56 (1.02, 2.39)
>6 and ≤ 8dB 37/265 (13.96) 1.68 (1.08, 2.59) 1.62 (1.03, 2.54)
Whether the locus neighbored a locus with 0 dB baseline sensitivity .047 .29
No 77/645 (11.94) Ref Ref
Yes 42/968 (4.34) 0.68 (0.46, 1.00) 0.78 (0.49, 1.24)
Eccentricity of locus** .18
Perifoveal 71/1030 (6.89) Ref N/A
Parafoveal 35/397 (8.82) 0.60 (0.35, 1.04)
Foveal 13/186 (6.99) 0.93 (0.67, 1.30)
Hemisphere .32
Superior 53/811 (6.54) Ref N/A
Inferior 66/802 (8.23) 0.81 (0.53, 1.22)
Nasal vs. Temporal .47
Nasal 54/753 (7.17) Ref N/A
Temporal 65/860 (7.56) 1.09 (0.86, 1.39)

N/A: not applicable because the variable was not included in the multivariable regression model since its univariate association had p>0.10.

*:

the p-value is for testing whether there was any significant difference in the outcome event probability comparing the different groups. Wald test results were used.

**:

Fovea: loci located on the ring of 2° eccentricity. Parafovea: loci located on the ring of 4° eccentricity. Perifovea: loci located on the rings of 6° to 10° eccentricity.

(OR: odds ratio. CI: confidence interval).